星空体育官方入口网站网址大全-登录入口官网

#T2DM患者#

64篇内容 | 1528人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=1717767, encodeId=7dbc1e1776726, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=新诊断T2DM患者的降糖治疗选择, objectType=article, longId=737611, objectId=51eee376119d, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=51eee376119d, replyNumber=0, likeNumber=61, createdTime=2023-01-28, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=51eee376119d, moduleTitle=新诊断T2DM患者的降糖治疗选择, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=51eee376119d)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717768, encodeId=d1b41e177681a, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=【每日播报】-对于新诊断T2DM患者，磺脲类各药物单药治疗疗效, objectType=article, longId=737874, objectId=5b10e378749f, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5b10e378749f, replyNumber=0, likeNumber=62, createdTime=2022-09-20, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5b10e378749f, moduleTitle=【每日播报】-对于新诊断T2DM患者，磺脲类各药物单药治疗疗效, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5b10e378749f)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717766, encodeId=52961e177663a, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=BMC Med：通过预测血糖反应制定个性化饮食对新诊断T2DM患者血糖控制和代谢健康的影响, objectType=article, longId=727224, objectId=4eace2722471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4eace2722471, replyNumber=0, likeNumber=78, createdTime=2023-03-25, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4eace2722471, moduleTitle=BMC Med：通过预测血糖反应制定个性化饮食对新诊断T2DM患者血糖控制和代谢健康的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4eace2722471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717763, encodeId=c0e91e17763e1, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=柳叶刀：Tirzepatide控制T2DM患者血糖的效果优于胰岛素，且不增加心血管疾病风险！, objectType=article, longId=218901, objectId=20b42189010c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=20b42189010c, replyNumber=0, likeNumber=64, createdTime=2021-12-01, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=20b42189010c, moduleTitle=柳叶刀：Tirzepatide控制T2DM患者血糖的效果优于胰岛素，且不增加心血管疾病风险！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=20b42189010c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717759, encodeId=4d6a1e1775938, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Cardiovasc Diabetol：钠糖共转运体抑制剂可显著降低T2DM患者的心血管事件风险, objectType=article, longId=214773, objectId=5c5c214e7305, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=5c5c214e7305, replyNumber=0, likeNumber=50, createdTime=2022-04-17, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=5c5c214e7305, moduleTitle=Cardiovasc Diabetol：钠糖共转运体抑制剂可显著降低T2DM患者的心血管事件风险, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=5c5c214e7305)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717764, encodeId=abe91e177647a, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=BM子刊：GLP-1受体激动剂治疗T2DM患者的真实体重变化、依从性和停药情况, objectType=article, longId=295500, objectId=4e5b295500be, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=4e5b295500be, replyNumber=0, likeNumber=66, createdTime=2022-07-06, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=4e5b295500be, moduleTitle=BM子刊：GLP-1受体激动剂治疗T2DM患者的真实体重变化、依从性和停药情况, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=4e5b295500be)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717761, encodeId=ce171e177610d, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=BMC ENDOCR DISORD：T2DM患者想保护肾功能，更要控制好体重！, objectType=article, longId=217386, objectId=b6e121e386a1, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=b6e121e386a1, replyNumber=0, likeNumber=63, createdTime=2022-08-25, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=b6e121e386a1, moduleTitle=BMC ENDOCR DISORD：T2DM患者想保护肾功能，更要控制好体重！, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=b6e121e386a1)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717765, encodeId=fc1c1e1776505, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响, objectType=article, longId=301367, objectId=c4b830136e91, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c4b830136e91, replyNumber=0, likeNumber=54, createdTime=2022-11-27, rootId=0, userName=柳叶一刀, userId=778d36, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c4b830136e91, moduleTitle=Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c4b830136e91)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717762, encodeId=a74d1e1776202, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响, objectType=article, longId=218712, objectId=149f218e125c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=149f218e125c, replyNumber=0, likeNumber=52, createdTime=2022-09-28, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=149f218e125c, moduleTitle=Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=149f218e125c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717760, encodeId=9d621e177608a, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Lancet Diabetes Endocrinol：GLP-1受体激动剂可降低T2DM患者的多种心血管及肾脏不良事件的发生率, objectType=article, longId=216263, objectId=a32e21626362, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a32e21626362, replyNumber=0, likeNumber=73, createdTime=2021-10-15, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a32e21626362, moduleTitle=Lancet Diabetes Endocrinol：GLP-1受体激动剂可降低T2DM患者的多种心血管及肾脏不良事件的发生率, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a32e21626362)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717757, encodeId=e29b1e177578c, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Gut: 粪菌移植有益于肥胖T2DM患者, objectType=article, longId=209676, objectId=e92b2096e6b2, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=e92b2096e6b2, replyNumber=0, likeNumber=96, createdTime=2021-05-07, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=e92b2096e6b2, moduleTitle=Gut: 粪菌移植有益于肥胖T2DM患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=e92b2096e6b2)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717758, encodeId=52311e177589d, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Gut: 粪菌移植有益于肥胖T2DM患者, objectType=article, longId=209677, objectId=86622096e7bb, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=86622096e7bb, replyNumber=0, likeNumber=43, createdTime=2022-02-25, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=86622096e7bb, moduleTitle=Gut: 粪菌移植有益于肥胖T2DM患者, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=86622096e7bb)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717756, encodeId=31e31e17756f1, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Diabetes Care：基线舒张压对T2DM患者强化降压获得的心血管结局和全因死亡率的影响 , objectType=article, longId=193537, objectId=c3c919353e6c, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=c3c919353e6c, replyNumber=0, likeNumber=54, createdTime=2021-04-09, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=c3c919353e6c, moduleTitle=Diabetes Care：基线舒张压对T2DM患者强化降压获得的心血管结局和全因死亡率的影响 , moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=c3c919353e6c)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717754, encodeId=afd51e177541b, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Diabetes Metab Res Rev: T2DM患者胖瘦不同，发病机制不同, objectType=article, longId=188906, objectId=684918890687, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=684918890687, replyNumber=0, likeNumber=68, createdTime=2020-11-09, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=684918890687, moduleTitle=Diabetes Metab Res Rev: T2DM患者胖瘦不同，发病机制不同, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=684918890687)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717755, encodeId=5bf71e177558f, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=将血糖稳定在适宜范围将改善COVID-19合并T2DM患者的临床结局, objectType=article, longId=193467, objectId=a1bb19346ed0, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=a1bb19346ed0, replyNumber=0, likeNumber=63, createdTime=2020-05-14, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=a1bb19346ed0, moduleTitle=将血糖稳定在适宜范围将改善COVID-19合并T2DM患者的临床结局, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=a1bb19346ed0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717753, encodeId=663a1e1775361, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=JAHA：T2DM患者减重后体重恢复，会削弱心血管获益, objectType=article, longId=181314, objectId=16c118131471, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=16c118131471, replyNumber=0, likeNumber=57, createdTime=2020-07-08, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=16c118131471, moduleTitle=JAHA：T2DM患者减重后体重恢复，会削弱心血管获益, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=16c118131471)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717752, encodeId=9c601e1775237, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=ADA 2019 | FPG GOAL研究首次揭示：T2DM患者更佳空腹血糖目标为6.1 mmol/L, objectType=article, longId=168178, objectId=6f871681e881, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=6f871681e881, replyNumber=0, likeNumber=73, createdTime=2019-09-26, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=6f871681e881, moduleTitle=ADA 2019 | FPG GOAL研究首次揭示：T2DM患者更佳空腹血糖目标为6.1 mmol/L, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=6f871681e881)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717750, encodeId=8eff1e17750ff, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=病例分享 | 初诊且病情较重的T2DM患者，降糖方案如何选？, objectType=article, longId=153518, objectId=fe2a153518cd, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=fe2a153518cd, replyNumber=0, likeNumber=59, createdTime=2019-10-14, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=fe2a153518cd, moduleTitle=病例分享 | 初诊且病情较重的T2DM患者，降糖方案如何选？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=fe2a153518cd)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717751, encodeId=d7c51e177519a, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=Diabetes Care：降低高CV事件风险T2DM患者DFU相关截肢率就用…, objectType=article, longId=154204, objectId=67a115420446, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=67a115420446, replyNumber=0, likeNumber=72, createdTime=2019-09-30, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=67a115420446, moduleTitle=Diabetes Care：降低高CV事件风险T2DM患者DFU相关截肢率就用…, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=67a115420446)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1717747, encodeId=6be01e1774777, content=<a href='/topic/show?id=f6b01e050d5' target=_blank style='color:#2F92EE;'>#T2DM患者#</a>, objectTitle=病例分享 |长病程T2DM患者治疗如何兼顾有效、安全、简便？, objectType=article, longId=144271, objectId=3b271442e14e, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/article/show_article.do?id=3b271442e14e, replyNumber=0, likeNumber=60, createdTime=2018-09-30, rootId=0, userName=stfoxst, userId=b70c32458048, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3b271442e14e, moduleTitle=病例分享 |长病程T2DM患者治疗如何兼顾有效、安全、简便？, moduleType=article, hrefUrl=//m.capotfarm.com/article/show_article.do?id=3b271442e14e)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

T2DM患者

2020-05-29

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

新诊断T2DM患者的降糖治疗选择

2023-01-28

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

【每日播报】-对于新诊断T2DM患者，磺脲类各药物单药治疗疗效

2022-09-20

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

BMC Med：通过预测血糖反应制定个性化饮食对新诊断T2DM患者血糖控制和代谢健康的影响

2023-03-25

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

柳叶刀：Tirzepatide控制T2DM患者血糖的效果优于胰岛素，且不增加心血管疾病风险！

2021-12-01

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Cardiovasc Diabetol：钠糖共转运体抑制剂可显著降低T2DM患者的心血管事件风险

2022-04-17

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

BM子刊：GLP-1受体激动剂治疗T2DM患者的真实体重变化、依从性和停药情况

2022-07-06

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

BMC ENDOCR DISORD：T2DM患者想保护肾功能，更要控制好体重！

2022-08-25

柳叶一刀 (审核中...)

前往app查看评论内容

#T2DM患者#

Cardiovasc Diabetol：GLP-1激动剂 vs SGLT-2抑制剂 vs DPP-4抑制剂对T2DM患者心肾结局的影响

2022-11-27

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Diabetes Obes Metab：SGLT-2抑制剂对T2DM患者血清尿酸水平的影响

2022-09-28

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Lancet Diabetes Endocrinol：GLP-1受体激动剂可降低T2DM患者的多种心血管及肾脏不良事件的发生率

2021-10-15

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Gut: 粪菌移植有益于肥胖T2DM患者

2021-05-07

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Gut: 粪菌移植有益于肥胖T2DM患者

2022-02-25

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Diabetes Care：基线舒张压对T2DM患者强化降压获得的心血管结局和全因死亡率的影响

2021-04-09

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Diabetes Metab Res Rev: T2DM患者胖瘦不同，发病机制不同

2020-11-09

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

将血糖稳定在适宜范围将改善COVID-19合并T2DM患者的临床结局

2020-05-14

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

JAHA：T2DM患者减重后体重恢复，会削弱心血管获益

2020-07-08

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

ADA 2019 | FPG GOAL研究首次揭示：T2DM患者更佳空腹血糖目标为6.1 mmol/L

2019-09-26

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

病例分享 | 初诊且病情较重的T2DM患者，降糖方案如何选？

2019-10-14

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

Diabetes Care：降低高CV事件风险T2DM患者DFU相关截肢率就用…

2019-09-30

stfoxst (审核中...)

前往app查看评论内容

#T2DM患者#

病例分享 |长病程T2DM患者治疗如何兼顾有效、安全、简便？

2018-09-30

科室
- - 订阅+
  - 更多科室
工具
服务